Advancing information highlight retatrutide, a dual stimulant for GLP-1R and GIPR, reveal encouraging potential in managing obesity and connected metabolic ailments. Preliminary studies show notable weight loss and https://retatrutideresearchlab.co.uk/product-category/peptide/